This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 4 MG/ML VIAL is a generic product labeled by Mylan Institutional LLC, priced at $0.6735 per ML under NDC 67457042312. Its NADAC has been published 512 times since May 21, 2014.
FDA first approved this application on Aug 29, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Mylan Institutional LLCNDC
67457042312
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA040803FDA Approved
8/29/2008
TE Code
AP
On Market Since
5/11/2011
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 4 MG/ML VIAL has been published 512 times since May 21, 2014, and over the history we have for it it has declined 96.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6735 per ML |
|---|---|
| All-time high | $19.7260 (Jun 18, 2014) |
| All-time low | $0.5590 (Sep 20, 2017) |
| 52-week high | $0.8198 |
| 52-week low | $0.6575 |
| Median price | $0.8045 |
| Average price | $1.3254 |
| Largest weekly change | +152.4% (Nov 22, 2017) |
| Weeks tracked | 512 |
| Tracking since | May 21, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone Sodium Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 4 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 4 MG/ML VIAL, manufactured by Mylan Institutional LLC, is $0.6735 per ML (NDC 67457042312), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 4 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 4 MG/ML VIAL has declined 96.6%. It has been tracked across 512 weekly CMS publications since May 21, 2014.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 4 MG/ML VIAL?
Since May 21, 2014, the NADAC for DEXAMETHASONE 4 MG/ML VIAL has ranged from a low of $0.5590 (Sep 20, 2017) to a high of $19.7260 (Jun 18, 2014), with a median of $0.8045 per ML.
Are there cheaper alternatives to DEXAMETHASONE 4 MG/ML VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 20 MG/5 ML VIAL, is $0.2014 per ML — about 70% below DEXAMETHASONE 4 MG/ML VIAL.
Who manufactures DEXAMETHASONE 4 MG/ML VIAL?
DEXAMETHASONE 4 MG/ML VIAL (NDC 67457042312) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.
Is DEXAMETHASONE 4 MG/ML VIAL in shortage?
Yes — NDC 67457042312 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).